Germline MC1R status influences somatic mutation burden in melanoma
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
The major genetic determinants of cutaneous melanoma risk in the general population are disruptive variants ( R alleles) in the melanocortin 1 receptor ( MC1R ) gene. These alleles are also linked to red hair, freckling, and sun sensitivity, all of which are known melanoma phenotypic risk factors. Here we report that in melanomas and for somatic C>T mutations, a signature linked to sun exposure, the expected single-nucleotide variant count associated with the presence of an R allele is estimated to be 42% (95% CI, 15–76%) higher than that among persons without an R allele. This figure is comparable to the expected mutational burden associated with an additional 21 years of age. We also find significant and similar enrichment of non-C>T mutation classes supporting a role for additional mutagenic processes in melanoma development in individuals carrying R alleles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Melanomas featuring disruptive mutations in MC1R are associated with a 42% increase in UV-signature mutations over those in MC1R wild-type melanomas75.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: PKA-Mediated Phosphorylation of ATR Promotes Recruitment of XPA to UV-Induced DNA Damage
Jarrett, S. G., Horrell, E. M. W., Christian, P. A., Vanover, J. C., Boulanger, M. C., Zou, Y., & D’Orazio, J. A. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.030 · Cited by 85
Retractedmice: Multivariate Imputation by Chained Equations in R
Buuren, S. V., & Groothuis-Oudshoorn, K. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i03 · Cited by 13,870
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citationSIFT: predicting amino acid changes that affect protein function
Ng, P. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg509 · Cited by 6,577
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S., & Getz, G. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,981
Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2
Adzhubei, I., Jordan, D. M., & Sunyaev, S. R. (2013) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0720s76 · Cited by 3,705
Genomic classification of cutaneous melanoma
Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., Arachchi, H., Arora, A., Auman, J. T., Ayala, B., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.044 · Cited by 3,151
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Forbes, S. A., Beare, D., Gunasekaran, P., Leung, K., Bindal, N., Boutselakis, H., Ding, M., Bamford, S., Cole, C., Ward, S., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1075 · Cited by 2,283
Hierarchical Dirichlet Processes
Teh, Y. W., Jordan, M. I., Beal, M. J., & Blei, D. M. (2006) · Journal of the American Statistical Association · doi:10.1198/016214506000000302 · Cited by 2,120
A comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696
Yates, A., Akanni, W., Amode, M. R., Barrell, D., Billis, K., Carvalho-Silva, D., Cummins, C., Clapham, P., Fitzgerald, S., Gil, L., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1157 · Cited by 1,273
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Krauthammer, M., Kong, Y., Ha, B. H., Evans, P., Bacchiocchi, A., McCusker, J. P., Cheng, E., Davis, M. J., Goh, G., Choi, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.2359 · Cited by 1,191
Self-citationValverde, P., Healy, E., Jackson, I., Rees, J. L., & Thody, A. J. (1995) · Nature Genetics · doi:10.1038/ng1195-328 · Cited by 999
Melanoma genome sequencing reveals frequent PREX2 mutations
Berger, M. F., Hodis, E., Heffernan, T. P., Deribe, Y. L., Lawrence, M. S., Protopopov, A., Ivanova, E., Watson, I. R., Nickerson, E., Ghosh, P., et al. (2012) · Nature · doi:10.1038/nature11071 · Cited by 756
Multiple imputation with multivariate imputation by chained equation (MICE) package.
Zhang, Z. (2016) · PubMed · doi:10.3978/j.issn.2305-5839.2015.12.63 · Cited by 740
Mitra, D., Luo, X., Morgan, A., Wang, J., Hoang, M. P., Lo, J., Guerrero, C. R., Lennerz, J. K., Mihm, M. C., Wargo, J. A., et al. (2012) · Nature · doi:10.1038/nature11624 · Cited by 497
Genome-wide association study identifies three loci associated with melanoma risk
Bishop, D. T., Demenais, F., Iles, M. M., Harland, M., Taylor, J. C., Corda, E., Randerson-Moor, J., Aitken, J. F., Avril, M.-F., Azizi, E., et al. (2009) · Nature Genetics · doi:10.1038/ng.411 · Cited by 462
Melanocytes as Instigators and Victims of Oxidative Stress
Denat, L., Kadekaro, A. L., Marrot, L., Leachman, S. A., & Abdel-Malek, Z. A. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.65 · Cited by 416
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
Krauthammer, M., Kong, Y., Bacchiocchi, A., Evans, P., Pornputtapong, N., Wu, C., McCusker, J. P., Ma, S., Cheng, E., Straub, R., et al. (2015) · Nature Genetics · doi:10.1038/ng.3361 · Cited by 402
Self-citationMC1R variants, melanoma and red hair color phenotype: A meta‐analysis
Raimondi, S., Sera, F., Gandini, S., Iodice, S., Caini, S., Maisonneuve, P., & Fargnoli, M. C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23396 · Cited by 349
Interactive effects of MC1R and OCA2 on melanoma risk phenotypes
Duffy, D. L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh043 · Cited by 257
MC 1R, Eumelanin and Pheomelanin: Their Role in Determining the Susceptibility to Skin Cancer
Nasti, T. H., & Timares, L. (2015) · Photochemistry and Photobiology · doi:10.1111/php.12335 · Cited by 217
MC 1R, the c AMP pathway, and the response to solar UV: extending the horizon beyond pigmentation
García‐Borrón, J. C., Abdel‐Malek, Z., & Jiménez‐Cervantes, C. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12257 · Cited by 187
Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles
Beaumont, K. A., Shekar, S. L., Newton, R. A., James, M. R., Stow, J. L., Duffy, D. L., & Sturm, R. A. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm177 · Cited by 171
MC1R Is a Potent Regulator of PTEN after UV Exposure in Melanocytes
Cao, J., Wan, L., Hacker, E., Dai, X., Lenna, S., Jimenez-Cervantes, C., Wang, Y., Leslie, N. R., Xu, G. X., Widlund, H. R., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.010 · Cited by 144
Self-citationWilliams, P. F., Olsen, C. M., Hayward, N. K., & Whiteman, D. C. (2011) · International Journal of Cancer · doi:10.1002/ijc.25804 · Cited by 143
Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair
Healy, E., Flannagan, N., Ray, A. J., Todd, C., Jackson, I. J., Matthews, J. N. S., Birch‐Machin, M. A., & Rees, J. L. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02042-0 · Cited by 143
The Cancer Genomics Hub (CGHub): overcoming cancer through the power of torrential data
Wilks, C., Cline, M. S., Weiler, E., Diehkans, M., Craft, B., Martin, C., Murphy, D., Pierce, H., Black, J., Nelson, D., et al. (2014) · Database · doi:10.1093/database/bau093 · Cited by 143
Hauser, J. E., Kadekaro, A. L., Kavanagh, R. J., Wakamatsu, K., Terzieva, S., Schwemberger, S., Babcock, G., Rao, M. B., Ito, S., & Abdel‐Malek, Z. A. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00315.x · Cited by 128
The Role of Melanocortin‐1 Receptor Polymorphism in Skin Cancer Risk Phenotypes
Sturm, R. A., Duffy, D. L., Box, N. F., Chen, W., Smit, D. J., Brown, D. L., Stow, J. L., Leonard, J. H., & Martin, N. G. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00041.x · Cited by 117
Pasquali, E., García‐Borrón, J. C., Fargnoli, M. C., Gandini, S., Maisonneuve, P., Bagnardi, V., Specchia, C., Liu, F., Kayser, M., Nijsten, T., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29018 · Cited by 117
Newton-Bishop, J. A., Chang, Y.-M., Elliott, F., Chan, M., Leake, S., Karpavicius, B., Haynes, S., Fitzgibbon, E., Kukalizch, K., Randerson-Moor, J., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.10.008 · Cited by 113
Olsen, C. M., Carroll, H. J., & Whiteman, D. C. (2010) · International Journal of Cancer · doi:10.1002/ijc.25243 · Cited by 89
Red hair is the null phenotype of MC1R
Beaumont, K. A., Shekar, S. N., Cook, A. L., Duffy, D. L., & Sturm, R. A. (2008) · Human Mutation · doi:10.1002/humu.20788 · Cited by 81
Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study
Davies, J. R., Randerson‐Moor, J., Kukalizch, K., Harland, M., Kumar, R., Madhusudan, S., Nagore, E., Hansson, J., Höiom, V., Ghiorzo, P., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.00982.x · Cited by 70
Swope, V., Alexander, C., Starner, R., Schwemberger, S., Babcock, G., & Abdel‐Malek, Z. A. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12252 · Cited by 67
Melanocortins and the melanocortin 1 receptor, moving translationally towards melanoma prevention
ABDEL‐MALEK, Z. A., Swope, V. B., Starner, R. J., Koikov, L. N., Cassidy, P. B., & Leachman, S. A. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.07.002 · Cited by 65
Circulating micro ribonucleic acids in cardiovascular disease: a look beyond myocardial injury
Mair, J. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.10.67 · Cited by 55
Jarrett, S. G., Wolf Horrell, E. M., Boulanger, M. C., & D'Orazio, J. A. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.280 · Cited by 54
Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis
Dwyer, T., van der Mei, I. A. F., Ponsonby, A., Taylor, B. V., Stankovich, J. M., McKay, J., Thomson, R. J., Polanowski, A. M., & Dickinson, J. L. (2008) · Neurology · doi:10.1212/01.wnl.0000323928.57408.93 · Cited by 53
Rate Limiting Factors in Melanocortin 1 Receptor Signalling Throughthe cAMP Pathway
Mas, J. S., Gerritsen, I., Hahmann, C., Jiménez‐Cervantes, C., & García-Borrón, J. C. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00073.x · Cited by 52
Jagirdar, K., Yin, K., Harrison, M., Lim, W., Muscat, G. E. O., Sturm, R. A., & Smith, A. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078075 · Cited by 39
Cassidy, P. B., ABDEL‐MALEK, Z. A., & Leachman, S. A. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.349 · Cited by 18
Shriber, P., Leitner‐Dagan, Y., Geacintov, N. E., Paz-Elizur, T., & Livneh, Z. (2015) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2015.08.002 · Cited by 16
Ozola, A., Azarjana, K., Doniņa, S., Proboka, G., Mandrika, I., Petrovska, R., Čēma, I., Heisele, O., Eņģele, L., Streinerte, B., et al. (2013) · Cancer Genetics · doi:10.1016/j.cancergen.2013.01.002 · Cited by 11
Ikehata, H., Ono, T., Tanaka, K., & Todo, T. (2007) · DNA repair · doi:10.1016/j.dnarep.2006.12.011 · Cited by 9
Analysis of Actively Transcribed DNA Repair Using a Transfection-Based System
Latimer, J. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-739-6_37 · Cited by 4
Cited by
Current state of melanoma diagnosis and treatment
Davis, L. E., Shalin, S. C., & Tackett, A. J. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1640032 · Cited by 922
“targeted therapies to treat each patient in a more personalized way based on the mutations they carry.(7,9,12-14)”
BackgroundMechanisms and prevention of UV‐induced melanoma
Sample, A., & He, Y. (2018) · Photodermatology, Photoimmunology & Photomedicine · doi:10.1111/phpp.12329 · Cited by 372
Kugel, C. H., Douglass, S. M., Webster, M. R., Kaur, A., Liu, Q., Yin, X., Weiss, S. A., Darvishian, F., Al-Rohil, R. N., Ndoye, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1116 · Cited by 367
“Unfortunately, we were not able to account for somatic mutational load which has previously been shown to increase with age (42), and predict patient response to PD1 inhibition (20).”
BackgroundLucas, R. M., Yazar, S., Young, A. R., Norval, M., de Gruijl, F. R., Takizawa, Y., Rhodes, L. E., Sinclair, C. A., & Neale, R. E. (2019) · Photochemical & Photobiological Sciences · doi:10.1039/c8pp90060d · Cited by 233
Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures
Khan, N. H., Mir, M., Qian, L., Baloch, M., Ali Khan, M. F., Rehman, A.-U., Ngowi, E. E., Wu, D.-D., & Ji, X.-Y. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2021.06.014 · Cited by 234
“Patients with MCIR variants, display less shielding from UV by pheomelanin and carry the improved UV signature mutation burden [57,58].”
Background
Metadata
- Authors
- Robles-Espinoza, C. D., Roberts, N. D., Chen, S., Leacy, F. P., Alexandrov, L. B., Pornputtapong, N., Halaban, R., Krauthammer, M., Cui, R., Timothy Bishop, D., & Adams, D. J.
- Affiliations
- Wellcome Sanger Institute (GB)
- Boston University (US)
- Royal College of Surgeons in Ireland (IE)
- Yale University (US)
- Corresponding author
- Adams, David J.
- ORCID
- Venue
- Nature Communications
- Published
- 2016-07-12
- Volume
- 7
- Issue
- 1
- Pages
- 12064-12064
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4945874
- OpenAlex
- W2474228978
- Cited by
- 124
- References
- 48
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 11 · 2023: 15 · 2022: 5 · 2021: 10 · 2020: 15 · 2019: 20 · 2018: 18 · 2017: 18 · 2016: 5
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Yale University (P50 CA121974)
- Wellcome Trust
- Cancer Research UK (13031, 10589, 19167)
- National Institutes of Health (UL1TR001863)
- National Cancer Institute (P50CA121974)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- MC1R, germline mutations, somatic mutation burden, cutaneous melanoma, sun exposure, mutational signatures, C>T mutations, melanoma risk
- MeSH terms
- Mutation Accumulation, Aged, Alleles, Female, Hair Color, Head and Neck Neoplasms, Humans, Male, Melanoma, Melanosis, Middle Aged, Mutation, Neoplasm Invasiveness, Skin Neoplasms, Skin Pigmentation, Genetic Variation, Cohort Studies, Germ-Line Mutation, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Receptor, Melanocortin, Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.